Clear Labs is a Biotech company based in San Carlos, California. It has raised $131M in total funding. Latest round: Series D.
Clear Labs funding overview
Clear Labs is a Biotech company based in San Carlos, California. Clear Labs has raised $131M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in January 2025. The round record for Clear Labs runs through 2025; nothing later has been disclosed. Investors on record include Morgan Stanley, T. Rowe Price, Counterpoint Global, Felicis, GV, HBM Genomics and 6 others. 12 distinct backers are named across the disclosed rounds.
Clear Labs at a glance
Total raised
$131M
Latest round
Series D
Latest round date
January 2025
Industry
Biotech
Headquarters
San Carlos, California
Notable investors
Morgan Stanley, T. Rowe Price, Counterpoint Global, Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures
Frequently asked about Clear Labs funding
How much has Clear Labs raised?
Clear Labs has raised $131M in total disclosed funding across the rounds on record.
Who has invested in Clear Labs?
Morgan Stanley, T. Rowe Price, Counterpoint Global, Felicis, GV, HBM Genomics are named among the investors backing Clear Labs.
What was the latest Clear Labs funding round?
The most recent disclosed round is a Series D, announced in January 2025.
Where is Clear Labs based?
Clear Labs is based in San Carlos, California.
What sector does Clear Labs operate in?
Clear Labs is tracked under Biotech from San Carlos, California, with $131M in disclosed funding.
When did Clear Labs last raise?
The last disclosed Clear Labs round closed in January 2025 at Series D.
Totals shown for Clear Labs aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in San Carlos and the investors behind them below.
